Equities

Biohit Oyj

Biohit Oyj

Actions
Health CareMedical Equipment and Services
  • Price (EUR)2.30
  • Today's Change-0.02 / -0.86%
  • Shares traded6.37k
  • 1 Year change+18.86%
  • Beta0.6453
Data delayed at least 15 minutes, as of Nov 21 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments6.816.235.52
Total Receivables, Net4.132.752.72
Total Inventory0.890.920.75
Prepaid expenses------
Other current assets, total----0.00
Total current assets129.908.98
Property, plant & equipment, net0.770.990.42
Goodwill, net------
Intangibles, net0.180.040.14
Long term investments0.120.060.06
Note receivable - long term------
Other long term assets--0.00--
Total assets13119.61
LIABILITIES
Accounts payable0.470.680.58
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.280.260.07
Other current liabilities, total2.321.931.51
Total current liabilities3.062.862.15
Total long term debt0.430.690.16
Total debt0.700.940.22
Deferred income tax0.000.000.00
Minority interest------
Other liabilities, total0.010.010.01
Total liabilities3.493.562.31
SHAREHOLDERS EQUITY
Common stock2.352.352.35
Additional paid-in capital5.215.145.14
Retained earnings (accumulated deficit)3.841.780.98
Treasury stock - common------
Unrealized gain (loss)(1.87)(1.7)(1.09)
Other equity, total(0.09)(0.11)(0.08)
Total equity9.437.467.30
Total liabilities & shareholders' equity13119.61
Total common shares outstanding151515
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.